Protective effects of schizandrin and schizandrin B towards cisplatin nephrotoxicity in vitro

27Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Renal proximal tubular epithelial cells are the main targets of toxic drugs such as cisplatin (CisPt), an alkylating agent indicated for the treatment of solid organ tumors. Current techniques aiming at reducing nephrotoxicity in patients receiving CisPt are still not satisfactory as they can only partially prevent acute kidney injury. New nephroprotective strategies remain to be developed. In the present in vitro study, schizandrin (Schi) and schizandrin B (Schi B), major phytochemicals from Schisandra chinensis (Turcz.) Baill. fruits, were tested on HK-2 cells along four processes that could help alleviate CisPt toxicity. Results indicated that: (i) both Schi and Schi B enhanced cell survival via reducing apoptosis rate; (ii) only Schi showed moderate effects towards modulation of regeneration capacities of healthy cells; (iii) both Schi and Schi B limited extracellular matrix deposition; and (iv) both compounds could help preventing dedifferentiation processes via the β-catenin pathway. Schi and Schi B present promising activities for future development of protective agents against CisPt nephrotoxicity.

Cite

CITATION STYLE

APA

Bunel, V., Antoine, M. H., Nortier, J., Duez, P., & Stévigny, C. (2014). Protective effects of schizandrin and schizandrin B towards cisplatin nephrotoxicity in vitro. Journal of Applied Toxicology, 34(12), 1311–1319. https://doi.org/10.1002/jat.2951

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free